|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2015. CA Cancer J Clin. 65:5–29. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Xue J, Chen Z, Gu X, Zhang Y and Zhang W:
MicroRNA-148a inhibits migration of breast cancer cells by
targeting MMP-13. Tumour Biol. 37:1581–1590. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Sharma S, Kelly TK and Jones PA:
Epigenetics in cancer. Carcinogenesis. 31:27–36. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Beckmann MW, Niederacher D, Schnurch HG,
Gusterson BA and Bender HG: Multistep carcinogenesis of breast
cancer and tumour heterogeneity. J Mol Med (Berl). 75:429–439.
1997. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Gradishar WJ: Treatment of metastatic
breast cancer. J Natl Compr Canc Netw. 12 5 Suppl:S759–S761. 2014.
View Article : Google Scholar
|
|
7
|
Martin HL, Smith L and Tomlinson DC:
Multidrug-resistant breast cancer: Current perspectives. Breast
Cancer (Dove Med Press). 6:1–13. 2014.PubMed/NCBI
|
|
8
|
Takahashi RU, Miyazaki H and Ochiya T: The
roles of MicroRNAs in breast cancer. Cancers (Basel). 7:598–616.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Gamucci T, D'Ottavio AM, Magnolfi E,
Barduagni M, Vaccaro A, Sperduti I, Moscetti L, Belli F and Meliffi
L: Weekly epirubicin plus docetaxel as first-line treatment in
metastatic breast cancer. Br J Cancer. 97:1040–1045. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Chaffer CL and Weinberg RA: A perspective
on cancer cell metastasis. Science. 331:1559–1564. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wan L, Pantel K and Kang Y: Tumor
metastasis: Moving new biological insights into the clinic. Nat
Med. 19:1450–1464. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wang Z and Ouyang G: Periostin: A bridge
between cancer stem cells and their metastatic niche. Cell Stem
Cell. 10:111–112. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Teng G and Papavasiliou FN: Shhh!
Silencing by microRNA-155. Philos Trans R Soc Lond B Biol Sci.
364:631–637. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Hydbring P and Badalian-Very G: Clinical
applications of microRNAs. F1000Res. 2:1362013.PubMed/NCBI
|
|
15
|
Gromak N: Intronic microRNAs: A crossroad
in gene regulation. Biochem Soc Trans. 40:759–761. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Bartel DP: MicroRNAs: Target recognition
and regulatory functions. Cell. 136:215–233. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Hwang HW and Mendell JT: MicroRNAs in cell
proliferation, cell death, and tumorigenesis. Br J Cancer. 96
Suppl:R40–R44. 2007.PubMed/NCBI
|
|
18
|
Ryan BM, Robles AI and Harris CC: Genetic
variation in microRNA networks: The implications for cancer
research. Nat Rev Cancer. 10:389–402. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Shukla GC, Singh J and Barik S: MicroRNAs:
Processing, maturation, target recognition and regulatory
functions. Mol Cell Pharmacol. 3:83–92. 2011.PubMed/NCBI
|
|
20
|
Wu D, Zhou Y, Pan H, Zhou J, Fan Y and Qu
P: microRNA-99a inhibiting cell proliferation, migration and
invasion by targeting fibroblast growth factor receptor 3 in
bladder cancer. Oncol Lett. 7:1219–1224. 2014.PubMed/NCBI
|
|
21
|
Wu D, Pan H, Zhou Y, Zhang Z, Qu P, Zhou J
and Wang W: Upregulation of microRNA-204 inhibits cell
proliferation, migration and invasion in human renal cell carcinoma
cells by downregulating SOX4. Mol Med Rep. 12:7059–7064.
2015.PubMed/NCBI
|
|
22
|
Wang CZ, Yuan P and Li Y: MiR-126
regulated breast cancer cell invasion by targeting ADAM9. Int J
Clin Exp Pathol. 8:6547–6553. 2015.PubMed/NCBI
|
|
23
|
van Schooneveld E, Wildiers H, Vergote I,
Vermeulen PB, Dirix LY and Van Laere SJ: Dysregulation of microRNAs
in breast cancer and their potential role as prognostic and
predictive biomarkers in patient management. Breast Cancer Res.
17:212015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
He Z, Xia Y, Pan C, Ma T, Liu B, Wang J,
Chen L and Chen Y: Up-Regulation of MiR-452 inhibits metastasis of
non-small cell lung cancer by regulating BMI1. Cell Physiol
Biochem. 37:387–398. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kristensen H, Haldrup C, Strand S,
Mundbjerg K, Mortensen MM, Thorsen K, Ostenfeld MS, Wild PJ, Arsov
C, Goering W, et al: Hypermethylation of the GABRE~miR-452~miR-224
promoter in prostate cancer predicts biochemical recurrence after
radical prostatectomy. Clin Cancer Res. 20:2169–2181. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Liu L, Chen K, Wu J, Shi L, Hu B, Cheng S,
Li M and Song L: Downregulation of miR-452 promotes stem-like
traits and tumorigenicity of gliomas. Clin Cancer Res.
19:3429–3438. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Wei C, Luo Q, Sun X, Li D, Song H, Li X,
Song J, Hua K and Fang L: MicroRNA-497 induces cell apoptosis by
negatively regulating Bcl-2 protein expression at the
posttranscriptional level in human breast cancer. Int J Clin Exp
Pathol. 8:7729–7739. 2015.PubMed/NCBI
|
|
29
|
Hong W and Dong E: The past, present and
future of breast cancer research in China. Cancer Lett. 351:1–5.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Bockhorn J, Prat A, Chang YF, Liu X, Huang
S, Shang M, Nwachukwu C, Gomez-Vega MJ, Harrell JC, Olopade OI, et
al: Differentiation and loss of malignant character of spontaneous
pulmonary metastases in patient-derived breast cancer models.
Cancer Res. 74:7406–7417. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Erturk E, Cecener G, Polatkan V, Gokgoz S,
Egeli U, Tunca B, Tezcan G, Demirdogen E, Ak S and Tasdelen I:
Evaluation of genetic variations in miRNA-binding sites of BRCA1
and BRCA2 genes as risk factors for the development of early-onset
and/or familial breast cancer. Asian Pac J Cancer Prev.
15:8319–8324. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Sun EH, Zhou Q, Liu KS, Wei W, Wang CM,
Liu XF, Lu C and Ma DY: Screening miRNAs related to different
subtypes of breast cancer with miRNAs microarray. Eur Rev Med
Pharmacol Sci. 18:2783–2788. 2014.PubMed/NCBI
|
|
33
|
Cai ZK, Chen Q, Chen YB, Gu M, Zheng DC,
Zhou J and Wang Z: microRNA-155 promotes the proliferation of
prostate cancer cells by targeting annexin 7. Mol Med Rep.
11:533–538. 2015.PubMed/NCBI
|
|
34
|
Zheng Q, Sheng Q, Jiang C, Shu J, Chen J,
Nie Z, Lv Z and Zhang Y: MicroRNA-452 promotes tumorigenesis in
hepatocellular carcinoma by targeting cyclin-dependent kinase
inhibitor 1B. Mol Cell Biochem. 389:187–195. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Hu Q, Gong JP, Li J, Zhong SL, Chen WX,
Zhang JY, Ma TF, Ji H, Lv MM, Zhao JH and Tang JH: Down-regulation
of miRNA-452 is associated with adriamycin-resistance in breast
cancer cells. Asian Pac J Cancer Prev. 15:5137–5142. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Bhuin T and Roy JK: Rab11 in disease
progression. Int J Mol Cell Med. 4:1–8. 2015.PubMed/NCBI
|
|
37
|
Mosesson Y, Mills GB and Yarden Y:
Derailed endocytosis: An emerging feature of cancer. Nat Rev
Cancer. 8:835–850. 2008. View
Article : Google Scholar : PubMed/NCBI
|
|
38
|
Gelsi-Boyer V, Orsetti B, Cervera N,
Finetti P, Sircoulomb F, Rougé C, Lasorsa L, Letessier A, Ginestier
C, Monville F, et al: Comprehensive profiling of 8p11-12
amplification in breast cancer. Mol Cancer Res. 3:655–667. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Caswell PT, Chan M, Lindsay AJ, McCaffrey
MW, Boettiger D and Norman JC: Rab-coupling protein coordinates
recycling of alpha5beta1 integrin and EGFR1 to promote cell
migration in 3D microenvironments. J Cell Biol. 183:143–155. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Zhang J, Liu X, Datta A, Govindarajan K,
Tam WL, Han J, George J, Wong C, Ramnarayanan K, Phua TY, et al:
RCP is a human breast cancer-promoting gene with Ras-activating
function. J Clin Invest. 119:2171–2183. 2009.PubMed/NCBI
|
|
41
|
Wang B, Yang Z, Wang H, Cao Z, Zhao Y,
Gong C, Ma L, Wang X, Hu X and Chen S: MicroRNA-320a inhibits
proliferation and invasion of breast cancer cells by targeting
RAB11A. Am J Cancer Res. 5:2719–2729. 2015. View Article : Google Scholar : PubMed/NCBI
|
